The DOI matches its Crossref record.
Chondrogenic Potential of Human Adult Mesenchymal Stem Cells Is Independent of Age or Osteoarthritis Etiology
Abstract
Osteoarthritis (OA) is a multifactorial disease strongly correlated with history of joint trauma, joint dysplasia, and advanced age. Mesenchymal stem cells (MSCs) are promising cells for biological cartilage regeneration. Conflicting data have been published concerning the availability of MSCs from the iliac crest, depending on age and overall physical fitness. Here, we analyzed whether the availability and chondrogenic differentiation capacity of MSCs isolated from the femoral shaft as an alternative source is age- or OA etiology-dependent. MSCs were isolated from the bone marrow (BM) of 98 patients, categorized into three OA-etiology groups (age-related, joint trauma, joint dysplasia) at the time of total hip replacement. All BM samples were characterized for cell yield, proliferation capacity, and phenotype. Chondrogenic differentiation was studied using micromass culture and analyzed by histology, immunohistochemistry, and quantitative reverse transcriptase-polymerase chain reaction. Significant volumes of viable BM (up to 25 ml) could be harvested from the femoral shaft without observing donor-site morbidity, typically containing >107 mononuclear cells per milliliter. No correlation of age or OA etiology with the number of mononuclear cells in BM, MSC yield, or cell size was found. Proliferative capacity and cellular spectrum of the harvested cells were independent of age and cause of OA. From all tested donors, MSCs could be differentiated into the chondrogenic lineage. We conclude that, irrespective of age and OA etiology, sufficient numbers of MSCs can be isolated and that these cells possess an adequate chondrogenic differentiation potential. Therefore, a therapeutic application of MSCs for cartilage regeneration of OA lesions seems feasible. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kretlow, J. D., Jin, Y.-Q., Liu, W., Zhang, W. J., Hong, T.-H., Zhou, G., Baggett, L. S., Mikos, A. G., & Cao, Y. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-60 · Cited by 466
Mesenchymal stem cells in joint disease and repair
Barry, F., & Murphy, M. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.109 · Cited by 423
Battula, V. L., Treml, S., Bareiss, P. M., Gieseke, F., Roelofs, H., de Zwart, P., Muller, I., Schewe, B., Skutella, T., Fibbe, W. E., et al. (2009) · Haematologica · doi:10.3324/haematol.13740 · Cited by 349
Self-citationLamo-Espinosa, J. M., Mora, G., Blanco, J. F., Granero-Moltó, F., Nuñez-Córdoba, J. M., Sánchez-Echenique, C., Bondía, J. M., Aquerreta, J. D., Andreu, E. J., Ornilla, E., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0998-2 · Cited by 329
Zaim, M., Karaman, S., Cetin, G., & Isik, S. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1438-x · Cited by 294
Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy
Nöth, U., Steinert, A. F., & Tuan, R. S. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0816 · Cited by 279
Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis
Redondo, J., Sarkar, P., Kemp, K., Heesom, K. J., Wilkins, A., Scolding, N. J., & Rice, C. M. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0045 · Cited by 37
Metadata
- Authors
- Scharstuhl, A., Schewe, B., Benz, K., Gaissmaier, C., Bühring, H.-J., & Stoop, R.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-13
- Volume
- 25
- Issue
- 12
- Pages
- 3244-3251
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W1993811760
- Cited by
- 196
- References
- 0
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.